Hydrogel Based Drug Delivery System Market Report 2026

Hydrogel Based Drug Delivery System Market Overview

• Hydrogel Based Drug Delivery System market size has reached to $7.56 billion in 2025 • Expected to grow to $12.35 billion in 2030 at a compound annual growth rate (CAGR) of 10.2% • Growth Driver: Rising Burn Cases Is Fueling The Growth Of The Market Due To Increasing Incidents From Household Accidents And Need For Enhanced Wound Care • Market Trend: Advancements In Injectable Hydrogels For Targeted And Sustained Drug Delivery • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Hydrogel Based Drug Delivery System Market?

A hydrogel-based drug delivery system is a network of hydrophilic polymers that can absorb and retain large amounts of water while maintaining a gel-like structure. It enables controlled and sustained release of drugs at targeted sites within the body. This system improves drug stability, bioavailability, and patient compliance by allowing precise dosage and reduced side effects. The main types of hydrogels in hydrogel-based drug delivery systems are natural hydrogels, synthetic hydrogels, and hybrid hydrogels. Natural hydrogels are water-absorbing materials derived from natural polymers that mimic living tissue and support biocompatible, controlled drug delivery and tissue healing. These hydrogels can carry different drug types, including small molecules, large molecules, peptides, and proteins, and are administered through various routes of administration, such as topical, injectable, oral, transdermal, and ocular. It is applicable for applications including cardiology, oncology, immunology, pain management, and others. and used by several end users, including hospitals, clinics, research institutes, and others.

What Is The Hydrogel Based Drug Delivery System Market Growth Forecast?

The hydrogel based drug delivery system market size is expected to see rapid growth in the next few years. It will grow to $12.35 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to development of synthetic and hybrid hydrogels, increasing focus on oncology and cardiology applications, expansion of injectable and ocular delivery routes, rising adoption of personalized hydrogel therapies, growing investment in research institutes and hospitals. Major trends in the forecast period include rising adoption of injectable and topical hydrogel drug delivery systems, increasing use of hydrogels for targeted oncology and cardiology therapies, development of hybrid hydrogels for enhanced drug release profiles, expansion of research on peptides, proteins, and large molecule delivery, growth in personalized medicine and patient-specific drug formulations.

Global Hydrogel Based Drug Delivery System Market Segmentation

1) By Type Of Hydrogel: Natural Hydrogels, Synthetic Hydrogels, Hybrid Hydrogels 2) By Drug Type: Small Molecules, Large Molecules, Peptides, Proteins 3) By Route Of Administration: Topical, Injectable, Oral, Transdermal, Ocular 4) By Application: Cardiology, Oncology, Immunology, Pain Management, Other Applications 5) By End-User: Hospitals, Clinics, Research Institutes, Other End-Users Subsegments: 1) By Natural Hydrogels: Alginate, Chitosan, Collagen, Gelatin, Hyaluronic Acid, Fibrin 2) By Synthetic Hydrogels: Polyethylene Glycol (PEG), Polyvinyl Alcohol (PVA), Polyacrylamide (PAAm), Poloxamer, Poly(N-isopropylacrylamide) (PNIPAM) 3) By Hybrid Hydrogels: Natural-Synthetic Polymer Blends, Interpenetrating Polymer Networks (IPNs), Composite Hydrogels, Nanocomposite Hydrogels

What Is The Driver Of The Hydrogel Based Drug Delivery System Market?

The growing prevalence of burn cases is expected to propel the growth of the hydrogel-based drug delivery system market going forward. Burn cases are medical situations in which patients suffer damage to the skin or deeper tissues due to heat, chemicals, electricity, or radiation. Burn cases are rising due to more household accidents from mishandling hot liquids or cooking equipment, causing skin injuries, emphasizing the need for improved safety awareness in daily activities. Hydrogel-based drug delivery systems support burn recovery by maintaining a moist, protective environment that accelerates healing and alleviates pain while delivering medications in a controlled, sustained manner to enhance tissue repair and prevent infection. For instance, in October 2023, according to the International Burn Injury Database (iBID), a US-based organization, in the first six months of 2023, burns and scalds among children increased by 45% compared with the same period in 2022, while incidents involving adults and the elderly from hot water bottles rose by 19%. Therefore, the growing prevalence of burn cases is driving the growth of the hydrogel-based drug delivery system market.

Key Players In The Global Hydrogel Based Drug Delivery System Market

Major companies operating in the hydrogel based drug delivery system market are Johnson & Johnson, Merck KGaA, UPM Biomedicals Oy, The Lubrizol Corporation, Ashland Global Holdings Inc., B. Braun Melsungen AG, Ocular Therapeutix Inc., Primex ehf, Heppe Medical Chitosan GmbH, BioCat GmbH, Micropore Technologies Limited, Akina Inc., KitoZyme SA

Global Hydrogel Based Drug Delivery System Market Trends and Insights

Major companies operating in the hydrogel-based drug delivery market are focusing on developing advanced products such as injectable hydrogels to improve targeted delivery and enable controlled, sustained drug release. Injectable hydrogels are soft, water-based materials administered minimally invasively into the body, delivering drugs with controlled, sustained release directly at the target site, enhancing effectiveness and minimizing side effects. For instance, in October 2024, UPM Biomedicals Oy, a Finland-based biotechnology company, launched Fibgel, the world’s first injectable nanocellulose hydrogel designed specifically for permanent implantable medical devices. This innovative hydrogel is made from renewable Finnish birch wood cellulose and water, providing a safe, sustainable, and animal-free alternative to traditional synthetic and animal-derived hydrogels. Fibgel offers tunable mechanical properties and excellent biocompatibility, enabling controlled and sustained drug release directly at the target site. Its shear-thinning nature allows easy injection with minimally invasive procedures, improving patient comfort and accelerating recovery.

What Are Latest Mergers And Acquisitions In The Hydrogel Based Drug Delivery System Market?

In May 2025, AmacaThera Inc., a Canada-based biotechnology company specializing in sustained-release hydrogel technologies for therapeutic applications, partnered with Merck Animal Health USA LLC to advance hydrogel-based drug delivery for veterinary medicine. With this partnership, Merck Animal Health USA LLC aims to expand its veterinary medicine portfolio by leveraging AmacaThera Inc.’s innovative hydrogel platform technology to develop long-acting, sustained-release formulations that improve animal health and welfare, offering more effective and convenient treatment options for veterinarians and pet owners. Merck Animal Health USA LLC is a US-based animal healthcare company.

Regional Insights

North America was the largest region in the hydrogel-based drug delivery system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Hydrogel Based Drug Delivery System Market?

The hydrogel-based drug delivery system market consists of sales of periodontal hydrogels, hydrogel-based microneedle patches, hydrogel-coated drug-eluting stents, hydrogel-based tissue adhesive systems, and hydrogel-encapsulated cell or gene delivery systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hydrogel Based Drug Delivery System Market Report 2026?

The hydrogel based drug delivery system market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hydrogel based drug delivery system industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.